IONS
Ionis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$58.09
−0.07%Margins
Gross margin
98.2%
EBITDA margin
495.6%
EBIT margin
-68.1%
Net margin
-64.6%
FCF margin
-64.0%
-128.4%
Return on equity
-18.9%
Return on assets
-20.8%
Return on invested capital
0.27x
Asset turnover
-$496.4M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026